XLM-USD vs. VRTX
XLM-USD (Stellar) is a cryptocurrency, while VRTX (Vertex Pharmaceuticals Incorporated) is a stock. Over the past 10 years, XLM-USD returned 60.23%/yr vs 17.15%/yr for VRTX. At a 0.05 correlation, their price movements are largely independent.
Performance
XLM-USD vs. VRTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLM-USD achieves a -6.87% return, which is significantly lower than VRTX's -1.86% return. Over the past 10 years, XLM-USD has outperformed VRTX with an annualized return of 60.23%, while VRTX has yielded a comparatively lower 17.15% annualized return.
XLM-USD
- 1D
- -1.52%
- 1M
- 15.17%
- YTD
- -6.87%
- 6M
- -21.39%
- 1Y
- -28.35%
- 3Y*
- 33.09%
- 5Y*
- -11.45%
- 10Y*
- 60.23%
VRTX
- 1D
- -0.03%
- 1M
- -1.22%
- YTD
- -1.86%
- 6M
- -1.57%
- 1Y
- -2.31%
- 3Y*
- 9.16%
- 5Y*
- 18.18%
- 10Y*
- 17.15%
XLM-USD vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLM-USD Stellar | -6.87% | -39.55% | 157.40% | 81.66% | -73.35% | 108.68% | 184.76% | -60.36% | -68.37% | 14,396.90% |
VRTX Vertex Pharmaceuticals Incorporated | -1.86% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | 7.94% | 32.13% | 10.58% | 103.42% |
Correlation
The correlation between XLM-USD and VRTX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Aug 4, 2014 | 0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLM-USD vs. VRTX — Risk / Return Rank
XLM-USD
VRTX
XLM-USD vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Stellar (XLM-USD) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XLM-USD | VRTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.24 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.02 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.40 | -0.14 | -0.26 |
| Martin ratioReturn relative to average drawdown | -0.57 | -0.29 | -0.28 |
Loading charts...
Drawdowns
XLM-USD vs. VRTX - Drawdown Comparison
The maximum XLM-USD drawdown since its inception was -96.21%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for XLM-USD and VRTX.
Loading charts...
Drawdown Indicators
| XLM-USD | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.21% | -91.77% | -4.44% |
Max Drawdown (1Y)Largest decline over 1 year | -71.19% | -23.56% | -47.63% |
Max Drawdown (3Y)Largest decline over 3 years | -74.37% | -29.07% | -45.30% |
Max Drawdown (5Y)Largest decline over 5 years | -83.25% | -29.07% | -54.18% |
Max Drawdown (10Y)Largest decline over 10 years | -96.21% | -41.60% | -54.61% |
Current DrawdownCurrent decline from peak | -78.80% | -13.90% | -64.90% |
Average DrawdownAverage peak-to-trough decline | -72.14% | -37.73% | -34.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.48% | 11.30% | +39.18% |
Volatility
XLM-USD vs. VRTX - Volatility Comparison
Stellar (XLM-USD) has a higher volatility of 43.48% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that XLM-USD's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XLM-USD | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 43.48% | 7.47% | +36.01% |
Volatility (6M)Calculated over the trailing 6-month period | 59.28% | 20.71% | +38.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.60% | 34.13% | +36.47% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.72% | 28.53% | +46.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 112.79% | 32.82% | +79.97% |
Frequently Asked Questions
XLM-USD and VRTX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XLM-USD has higher volatility (43.48%) compared to VRTX (7.47%). In terms of maximum drawdown, XLM-USD dropped -96.21% vs VRTX's -91.77%.
VRTX currently has the higher Sharpe Ratio (-0.10 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XLM-USD and VRTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer